144534-59-8

Basic information

• Product Name: 3-Cyclopentene-1-methanol, benzoate
• CAS NO: 144534-59-8
• Molecular Formula: C13H14O2
• Molecular Weight: 202.253
• Mol File: 144534-59-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-Cyclopentene-1-methanol, benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Cyclopentene-1-methanol, benzoate(144534-59-8)
• EPA Substance Registry System: 3-Cyclopentene-1-methanol, benzoate(144534-59-8)

Safety Data

• Hazardous Substances Data: 144534-59-8(Hazardous Substances Data)

Upstream product

• 25125-21-7 4-(hydroxymethyl)cyclopentene 
• 98-88-4 benzoyl chloride 

Downstream Products

• 155233-51-5 (1β, 3α, 4α)-(3,4-dihydroxy-1-cyclopentyl)methyl benzoate 
• 144534-63-4 anti-3-(benzyloxy)methyl-1,5-epoxycyclopentane 
• 144606-41-7 syn-3-(benzyloxy)methyl-1,5-epoxycyclopentane 
• 121481-90-1 (+/-)-cis-(4-hydroxymethyl)cyclopent-2-en-1-ylamine 
• 1036721-79-5 [(1β,3β,4β)-3,4-dihydroxycyclopentyl]methyl benzoate 

Relevant articles and documents

Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring

Antiviral purine nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Methods of treating herpes viral infections and pharmaceutical formulations are also described.

Therapeutic nucleosides-uses

Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue, particularly those in which the 2-, 5- and 6-positions of the benzimidazole base are substituted by halog

Novel synthesis of (+/-)-cis-4-amino-2-cyclopentene-1-methanol, a key intermediate in the preparation of carbocyclic 2',3'-didehydro-2',3'-dideoxy nucleosides

Novel synthetic routes directed toward the preparation of (+/-)-cis-4-amino-2-cyclopentene-1-methanol are described. The routes investigated involve azide openings of chiral and non-chiral cyclopentyl epoxides.